title: [BOMP (BLM, VCR, MMC, and CDDP) therapy for advanced cervical cancer].
authors.affiliation: Department of Obstetrics & Gynecology, Asahikawa Medical College.
authors.forename: Hideto
authors.initials: H
authors.lastname: Katayama
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Yamashita
authors.forename: Kazuo
authors.initials: K
authors.lastname: Sengoku
authors.forename: Mutsuo
authors.initials: M
authors.lastname: Ishikawa
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced; D016685:Mitomycin / Q000008:administration & dosage / Q000009:adverse effects; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009367:Neoplasm Staging; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D001761:Bleomycin; D016685:Mitomycin; D014750:Vincristine; D002945:Cisplatin